Botulinum toxin type A: all 754 studies that test it

Page 3 of 8. Open to participants first (87), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the EyelidCompletedNCT01896895Phase 3Results posted
• Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral PalsyCompletedNCT01893411Phase 3Results posted
• Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal SpasmCompletedNCT01859507Not applicableResults posted
• A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor OveractivityCompletedNCT01852058Phase 3Results posted
• Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric PatientsCompletedNCT01852045Phase 3Results posted
• Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®)CompletedNCT01833130Phase 4Results posted
• Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown LinesCompletedNCT01814670Phase 4Results posted
• Effect of Botox and Vibration on Bone in Children With Cerebral PalsyCompletedNCT01803464Not applicableResults posted
• BOTOX® in the Treatment of Upper Facial Lines in JapanCompletedNCT01797094Phase 3Results posted
• BOTOX® in the Treatment of Crow's Feet Lines in JapanCompletedNCT01797081Phase 3Results posted
• A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial RhytidesCompletedNCT01777620Phase 4Results posted
• Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical DystoniaCompletedNCT01753336Phase 3Results posted
• Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.CompletedNCT01753310Phase 3Results posted
• Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit DosesCompletedNCT01732809Phase 4Results posted
• Phase IV Study On Muscle Activity Of Two Commercial Preparations Of BotulinumCompletedNCT01728337Phase 4Results posted
• Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured PatientsCompletedNCT01682603Phase 2Results posted
• Comparing Lower-concentration Dysport Treatment Targeted to the Neuromuscular Junction With Current Clinical PracticeTerminatedNCT01682148Phase 3Results posted
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic MigraineCompletedNCT01662492Phase 3Results posted
• Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/ParkinsonismCompletedNCT01653132Phase 2Results posted
• HIV Posterior Cheek EnlargementCompletedNCT01635504Not applicableResults posted
• A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With RosaceaCompletedNCT01614743Phase 2Results posted
• BOTOX® Open-Label Treatment in Pediatric Lower Limb SpasticityCompletedNCT01603641Phase 3Results posted
• BOTOX® Treatment in Pediatric Lower Limb SpasticityCompletedNCT01603628Phase 3Results posted
• BOTOX® Open-Label Treatment in Pediatric Upper Limb SpasticityCompletedNCT01603615Phase 3Results posted
• BOTOX® Treatment in Pediatric Upper Limb SpasticityCompletedNCT01603602Phase 3Results posted
• Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and ArmCompletedNCT01603459Phase 3Results posted
• Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)CompletedNCT01600716Phase 3Results posted
• Botulinum Toxin A (Botox) in Tissue Expander Breast ReconstructionCompletedNCT01591746Phase 3Results posted
• Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTSCompletedNCT01589263Phase 2Results posted
• Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® RangeCompletedNCT01529203Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee PainCompletedNCT01518257Phase 1/2Results posted
• A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic MigraineCompletedNCT01516892Phase 4Results posted
• Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)CompletedNCT01502956Phase 3Results posted
• Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia FlexCompletedNCT01486264Phase 4Results posted
• Treatment of Vasopressor-induced Ischemia With Botulinum Toxin ATerminatedNCT01483209Not applicableResults posted
• Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a StrokeCompletedNCT01464307Phase 3Results posted
• Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin CancerTerminatedNCT01459666Phase 4Results posted
• Study of Botulinum Toxin and Recovery of Hand Function After StrokeCompletedNCT01422161Phase 3Results posted
• Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a StrokeCompletedNCT01392300Phase 3Results posted
• Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown LinesCompletedNCT01391312Phase 4Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown LinesCompletedNCT01391299Not applicableResults posted
• Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple SclerosisCompletedNCT01357980Phase 2Results posted
• Botox Injection for Treatment of VaginismusCompletedNCT01352546Phase 1Results posted
• Safety and Efficacy Study of Dysport RU and Glabellar LinesCompletedNCT01333397Phase 2Results posted
• MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb SpasticityCompletedNCT01313767Phase 3Results posted
• Dysport® Adult Upper Limb Spasticity Extension StudyCompletedNCT01313312Phase 3Results posted
• Dysport® Adult Upper Limb SpasticityCompletedNCT01313299Phase 3Results posted
• A Two-Part Study of BOTOX® Therapy for Ischemic DigitsCompletedNCT01309802Phase 2Results posted
• A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET)CompletedNCT01308060Phase 3Results posted
• Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)CompletedNCT01274611Not applicableResults posted
• Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar LinesCompletedNCT01271452Phase 4Results posted
• Study of BOTOX and JUVEDERM for Treatment of Moderate to Severe Facial Wrinkles and FoldsCompletedNCT01269801Phase 4Results posted
• Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical DystoniaCompletedNCT01261611Phase 3Results posted
• Dysport® Pediatric Lower Limb Spasticity Follow-on StudyCompletedNCT01251380Phase 3Results posted
• Dysport® Adult Lower Limb Spasticity Follow-on StudyCompletedNCT01251367Phase 3Results posted
• Dysport® Pediatric Lower Limb Spasticity StudyCompletedNCT01249417Phase 3Results posted
• Dysport® Adult Lower Limb Spasticity StudyCompletedNCT01249404Phase 3Results posted
• Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge IncontinenceCompletedNCT01226706Not applicableResults posted
• Botulinum Toxin A for Herpes LabialisTerminatedNCT01225341Not applicableResults posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown LinesCompletedNCT01224015Phase 3Results posted
• Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic ObstructionCompletedNCT01220726Phase 3Results posted
• A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb SpasticityCompletedNCT01205451Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown LinesCompletedNCT01189760Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet LinesCompletedNCT01189747Phase 3Results posted
• Anticholinergic vs. Botox Comparison StudyCompletedNCT01166438Phase 3Results posted
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb SpasticityCompletedNCT01153815Phase 3Results posted
• Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow StiffnessCompletedNCT01129583Not applicableResults posted
• Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT01107392Phase 2Results posted
• Calcitonin Gene-related Peptide Levels in Chronic MigraineCompletedNCT01071096Phase 4Results posted
• Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb JointTerminatedNCT01045694Phase 4Results posted
• Quality of Life and Self-esteem After Botox® Injections in Depressed and Non-depressed PatientsCompletedNCT01004042Phase 4Results posted
• Field of Effects of Two Commercial Preparations of Botulinum Toxin Type ACompletedNCT00989768Phase 4Results posted
• Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the FaceCompletedNCT00986570Phase 3Results posted
• Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum ToxinCompletedNCT00971620Phase 2Results posted
• Comparison of Two Commercial Preparations of Botulinum Toxin Type ACompletedNCT00959907Phase 4Results posted
• A Study to Compare Dysport® and Botox® in the Treatment of Cervical DystoniaCompletedNCT00950664Phase 4Results posted
• Idiopathic Hypertensive Anal Canal: a Place of Internal SphincterotomyCompletedNCT00927849Not applicableResults posted
• Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary IncontinenceCompletedNCT00915525Phase 3Results posted
• Study of the Safety and Efficacy of Botox in BruxismCompletedNCT00908050Phase 4Results posted
• Efficacy of Botulinum Toxin Injections in the Rectus Femoris to Treat Stiff Knee Gait Following Acquired Brain InjuryTerminatedNCT00900666Not applicableResults posted
• A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic HyperplasiaCompletedNCT00894517Phase 1/2Results posted
• A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple SclerosisCompletedNCT00876447Phase 3Results posted
• Botox Cosmetic and the Young Patient With Glabellar FurrowsCompletedNCT00856999Phase 4Results posted
• Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar LinesCompletedNCT00856414Phase 4Results posted
• Pilot Study of BOTOX for Migraine HeadachesTerminatedNCT00850421Not applicableResults posted
• Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder TrialTerminatedNCT00822926Not applicableResults posted
• Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction StudiesCompletedNCT00822523Not applicableResults posted
• H-22411: BOTOX® for Peyronie's DiseaseCompletedNCT00812838Phase 2Results posted
• Botox for Cervical Dystonia Following EMG MappingCompletedNCT00773253Phase 4Results posted
• IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown LinesCompletedNCT00770211Phase 3Results posted
• IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2CompletedNCT00770029Phase 3Results posted
• Safety and Efficacy of the Use of Botox on AcneTerminatedNCT00765375Phase 2Results posted
• Comparison of Two Botulinum Type A Products in the Treatment of BlepharospasmCompletedNCT00761592Phase 4Results posted
• Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome SyndromeTerminatedNCT00732680Phase 1/2Results posted
• Subcutaneous Botulinum Toxin for Cutaneous AllodyniaCompletedNCT00725322Not applicableResults posted
• Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)TerminatedNCT00711087Phase 2Results posted
• Over Active Bladder Instillation Study - BotoxTerminatedNCT00667095Phase 3Results posted
• Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and SpasticityCompletedNCT00661089Not applicableResults posted
• Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine HeadachesCompletedNCT00660192Phase 2/3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderTerminatedNCT00575016Phase 2Results posted

← Botulinum toxin type A overview